A Peroxisome ProliferatorActivated Receptor Activator Induces Renal CYP

  • Slides: 9
Download presentation
A Peroxisome Proliferator-Activated Receptor-α Activator Induces Renal CYP 2 C 23 Activity and Protects

A Peroxisome Proliferator-Activated Receptor-α Activator Induces Renal CYP 2 C 23 Activity and Protects from Angiotensin II-Induced Renal Injury Dominik N. Muller, Juergen Theuer, Erdenechimeg Shagdarsuren, Eva Kaergel, Horst Honeck, Joon-Keun Park, Marija Markovic, Eduardo Barbosa-Sicard, Ralf Dechend, Maren Wellner, Torsten Kirsch, Anette Fiebeler, Michael Rothe, Hermann Haller, Friedrich C. Luft, Wolf-Hagen Schunck The American Journal of Pathology Volume 164 Issue 2 Pages 521 -532 (February 2004) DOI: 10. 1016/S 0002 -9440(10)63142 -2 Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 1 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 1 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 2 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 2 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 3 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 3 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 4 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 4 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 5 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 5 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 6 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 6 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 7 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 7 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Figure 8 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002

Figure 8 The American Journal of Pathology 2004 164521 -532 DOI: (10. 1016/S 0002 -9440(10)63142 -2) Copyright © 2004 American Society for Investigative Pathology Terms and Conditions

Peroxisome ProliferatorActivated Receptor PPAR Can Inhibit Chronic RenalPeroxisome ProliferatorActivated Receptor PPAR Can Inhibit Chronic Renal
Transgenic expression of proximal tubule peroxisome proliferatoractivated receptorTransgenic expression of proximal tubule peroxisome proliferatoractivated receptor
Peroxisome ProliferatorActivated Receptor PPAR Agonists Preclinical and ClinicalPeroxisome ProliferatorActivated Receptor PPAR Agonists Preclinical and Clinical
Increased peroxisome proliferatoractivated receptor activity reduces imatinib uptakeIncreased peroxisome proliferatoractivated receptor activity reduces imatinib uptake
Activation of Peroxisome ProliferatorActivated Receptor in Dendritic CellsActivation of Peroxisome ProliferatorActivated Receptor in Dendritic Cells
Peroxisome ProliferatorActivated Receptor Protects Capillary Pericytes in thePeroxisome ProliferatorActivated Receptor Protects Capillary Pericytes in the
Peroxisome ProliferatorActivated Receptor Gamma Negatively Regulates the DifferentiationPeroxisome ProliferatorActivated Receptor Gamma Negatively Regulates the Differentiation
Increased peroxisome proliferatoractivated receptor activity reduces imatinib uptakeIncreased peroxisome proliferatoractivated receptor activity reduces imatinib uptake